CHINA PHARMA HOLDINGS, INC. Other Receivables, Net, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Other Receivables, Net, Current of $66.63 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Others
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-14
- 2026-06-30: Other Receivables, Net, Current $66.63K.
- 2026-03-31: Other Receivables, Net, Current $61.66K.
- 2025-12-31: Other Receivables, Net, Current $49.26K.
- 2025-09-30: Other Receivables, Net, Current $61.27K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2026-06-30 | $66.63K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $61.66K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $49.26K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $61.27K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $48.36K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $39.05K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $30.29K 10-K · filed 2026-04-01 |
| 2024-09-30 | $46.55K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $28.66K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $157.94K 10-K · filed 2025-03-31 |
| 2023-09-30 | $28.93K 10-Q · filed 2023-11-13 |
| 2022-12-31 | $29.14K 10-K · filed 2024-04-01 |
| 2014-12-31 | $272.20K 10-K · filed 2015-12-28 |
| 2014-09-30 | $516.10K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $482.86K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $203.30K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $175.74K 10-K · filed 2015-12-28 |
| 2013-09-30 | $541.13K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $556.01K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $255.29K 10-Q · filed 2013-05-14 |
| 2012-12-31 | $80.80K 10-K · filed 2014-03-20 |
| 2012-09-30 | $128.84K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $81.96K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $75.60K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $55.04K 10-K · filed 2013-03-14 |
| 2011-09-30 | $64.04K 10-Q/A · filed 2012-03-06 |
| 2011-06-30 | $82.24K 10-Q/A · filed 2011-09-06 |
| 2010-12-31 | $65.02K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |